Quantcast
Last updated on April 18, 2014 at 0:01 EDT

Latest Venous thrombosis Stories

2013-03-07 23:02:21

Dr. Cindy Asbjornsen, founder of the Vein Healthcare Center in Maine, explains deep vein thrombosis (DVT), its symptoms and prevention. South Portland, ME (PRWEB) March 07, 2013 Every year, approximately two million Americans suffer from the effects of blood clots in the deep vein system. According to vein specialist Dr. Cindy Asbjornsen of the Vein Healthcare Center, deep vein thrombosis (DVT), is a blood clot in the deep vein system. The danger of DVT is that the clot could break free...

2013-02-20 16:25:02

RIDGEFIELD, Conn., Feb. 20, 2013 /PRNewswire/ -- New findings from two double-blind, randomized trials, RE-MEDY(SM) and RE-SONATE(®), show that dabigatran 150 mg twice daily reduces the risk of recurrent venous thromboembolism (VTE)*. The results were published today in the New England Journal of Medicine. VTE is the third most common cardiovascular disorder after heart disease and stroke, and consists of two related conditions caused by blood clots: deep vein thrombosis (DVT) and...

2013-02-18 23:01:42

NuvaRing Side Effects Lawsuit Alleges Merck and Other Defendants Failed to Properly Disclose the Known Safety Hazards Associated with NuvaRing, Including an Increased Risk of Blood Clots Columbus, OH (PRWEB) February 18, 2013 Wright & Schulte LLC, an experienced defective medical device law firm, has filed a NuvaRing lawsuit on behalf of a South Carolina woman who developed two blood clots in her right leg, allegedly caused by NuvaRing. The NuvaRing lawsuit, which names Organon USA,...

2013-02-06 12:26:15

MUNICH, February 6, 2013 /PRNewswire/ -- The registry plans to gather data from more than 4,000 patients with VTE across seven European countries, providing insights into the clinical management of a disease that is a leading cause of morbidity and mortality[1] Daiichi Sankyo Europe GmbH announced the enrolment of the first patient into the PREvention oF thromboembolic events - European Registry in Venous ThromboEmbolism (PREFER in VTE). PREFER in...

2013-01-29 12:27:12

HIGH WYCOMBE, England, January 29, 2013 /PRNewswire/ -- European regulators have approved CE Mark extensions for the transformational geko [http://gekodevices.com/en-us ] device, designed to increase blood circulation for a range of circulatory disorders. Bosses at Firstkind Medical [http://gekodevices.com/en-us/contact/firstkind ], a wholly owned subsidiary of Sky Medical Technology [http://www.skymedtech.com ], say the decision will allow the geko(TM) device to move...

2013-01-16 22:10:44

Johns Hopkins research suggests routine preventive measures won't stop all clots Despite receiving blood thinners and other clot prevention treatment, some patients still develop potentially lethal blood clots in the first month after their operations anyway, especially if they developed a surgical-site infection while in the hospital, according to results of a study at Johns Hopkins. The research, described in a report published in the Journal of the American College of Surgeons, found...

2013-01-02 05:02:01

The DrugRisk Resource Center is the Web´s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Dallas, TX (PRWEB) January 01, 2013 The prescription drug resource center DrugRisk.com has added information to its already comprehensive online database showing use of the birth control drugs Yaz and Yasmin may be increasing, despite warnings about blood clot risks and the settlement of thousands of injury claims by Bayer....

2012-12-20 13:56:25

People with asthma have an increased risk of pulmonary embolism, according to new research. A new study, published online ahead of print today (20 December 2012) in the European Respiratory Journal, looked at whether people with moderate or severe asthma had an increased risk of developing deep vein thrombosis, or pulmonary embolism. Pulmonary embolism is when the main artery of the lung or the bronchi becomes blocked. It usually results from deep vein thrombosis; a blood clot in the...

2012-12-10 15:17:53

Studies presented today at the 54th Annual Meeting of the American Society of Hematology (ASH) examine current treatment standards for patients with clotting disorders in an effort to improve outcomes. The studies evaluate long-held treatment standards and whether modifications in intensity and duration of therapy may offer equally effective outcomes while reducing toxicities and relapse rates. Although significant advances have been made in delivering new and improved therapies for...

2012-12-08 05:02:49

The Drug Risk Resource Center is the Web´s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) December 07, 2012 The Drug Risk Resource Center, a patient awareness group, is alerting women prescribed the birth control Yaz or Yasmin that experts have related both the brand name and generic versions of the drugs to risks of blood clots. Bayer recently announced they are settling many of the claims...